Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells

Infection and Immunity

Volumn 79, Issue 3, 2011, Pages 1300-1310

  Veglia, Filippo ^a   Sciaraffia, Ester ^a   Riccomi, Antonella ^a   Pinto, Dora ^a   Negri, Donatella R M ^a   De Magistris, Maria Teresa ^a   Vendetti, Silvia ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CHOLERA TOXIN; FORSKOLIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CHOLERA TOXIN; DENDRITIC CELLS; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MONOCYTES; MYELOID CELLS; PHENOTYPE;

EID: 79952284706     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01181-10     Document Type: Article

References (61)

1. Anosova, N. G., et al. 2008. Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches. Mucosal Immunol. 1:59-67.
2. Arce, S., H. F. Nawar, G. Muehlinghaus, M. W. Russell, and T. D. Connell. 2007. In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis. Infect. Immun. 75:1413-1423.
3. Bagley, K. C., et al. 2003. Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin. Vaccine 21:3335-3341. (Pubitemid 36700432)
4. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
5. Bogunovic, M., et al. 2009. Origin of the lamina propria dendritic cell network. Immunity 31:513-525.
6. Braun, M. C., J. He, C. Y. Wu, and B. L. Kelsall. 1999. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J. Exp. Med. 189:541-552.
7. Bromander, A., J. Holmgren, and N. Lycke. 1991. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:2908-2914.
8. Cameron, A. J., M. M. Harnett, and J. M. Allen. 2001. Differential recruitment of accessory molecules by FcgammaRI during monocyte differentiation. Eur. J. Immunol. 31:2718-2725.
9. Chomarat, P., J. Banchereau, J. Davoust, and A. K. Palucka. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1:510-514.
10. Chomarat, P., C. Dantin, L. Bennett, J. Banchereau, and A. K. Palucka. 2003. TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 171:2262-2269.
11. Cong, Y., C. T. Weaver, and C. O. Elson. 1997. The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. J. Immunol. 159:5301-5308.
12. De Magistris, M. T. 2006. Mucosal delivery of vaccine antigens and its advantages in pediatrics. Adv. Drug Deliv. Rev. 58:52-57.
13. De Magistris, M. T., et al. 1998. Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization. Dev. Biol. Stand. 92:123-126.
14. Dickinson, B. L., and J. D. Clements. 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63:1617-1623.
15. Gagliardi, M. C., et al. 2000. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 30:2394-2403.
16. Gagliardi, M. C., et al. 2002. Effects of the adjuvant cholera toxin on dendritic cells: stimulatory and inhibitory signals that result in the amplification of immune responses. Int. J. Med. Microbiol. 291:571-575.
17. Geijtenbeek, T. B., J. den Dunnen, and S. I. Gringhuis. 2009. Pathogen recognition by DC-SIGN shapes adaptive immunity. Future Microbiol. 4:879-890.
18. Geijtenbeek, T. B., et al. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-585.
19. Geissmann, F., et al. 2008. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 86:398-408.
20. Ginhoux, F., et al. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7:265-273.
21. + (CD209) intermediate cell and impair differentiation into dendritic cells. J. Immunol. 171:6421-6430.
22. Hajishengallis, G., S. Arce, C. M. Gockel, T. D. Connell, and M. W. Russell. 2005. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections. J. Dent. Res. 84: 1104-1116.
23. Hajishengallis, G., H. Nawar, R. I. Tapping, M. W. Russell, and T. D. Connell. 2004. The type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells. Infect. Immun. 72:6351-6358.
24. Harandi, A. M., J. Sanchez, K. Eriksson, and J. Holmgren. 2003. Recent developments in mucosal immunomodulatory adjuvants. Curr. Opin. Investig. Drugs 4:156-161.
25. Holmgren, J., et al. 2005. Mucosal adjuvants and anti-infection and antiimmunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol. Lett. 97:181-188.
26. Itano, A. A., and M. K. Jenkins. 2003. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4:733-739.
27. - pulmonary dendritic cell populations. J. Immunol. 180:3019-3027.
28. Kaliński, P., J. H. Schuitemaker, C. M. Hilkens, and M. L. Kapsenberg. 1998. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161:2804-2809.
29. Kool, M., et al. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205:869-882.
30. Landsman, L., C. Varol, and S. Jung. 2007. Distinct differentiation potential of blood monocyte subsets in the lung. J. Immunol. 178:2000-2007. (Pubitemid 46233396)
31. + dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J. Exp. Med. 206:1227-1235.
32. Lavelle, E. C., et al. 2004. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J. Leukoc. Biol. 75:756-763.
33. Liu, K., et al. 2009. In vivo analysis of dendritic cell development and homeostasis. Science 324:392-397.
34. Lycke, N., and M. Bemark. 2010. Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins. Mucosal Immunol. 3:556-566.
35. Martino, A., et al. 2004. Dendritic cells derived from BCG-infected precursors induce Th2-like immune response. J. Leukoc. Biol. 76:827-834.
36. Martino, A., et al. 2005. Non-pathogenic Mycobacterium smegmatis induces the differentiation of human monocytes directly into fully mature dendritic cells. J. Clin. Immunol. 25:365-375.
37. Matousek, M. P., J. G. Nedrud, and C. V. Harding. 1996. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J. Immunol. 156:4137-4145.
38. Negri, D. R., et al. 2009. Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes. Infect. Immun. 77:1924-1935.
39. Niiya, H., et al. 2006. Human herpesvirus 6 impairs differentiation of monocytes to dendritic cells. Exp. Hematol. 34:642-653.
40. Novitskiy, S. V., et al. 2008. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112:1822-1831.
41. Otten, M. A., and M. van Egmond. 2004. The Fc receptor for IgA (FcalphaRI, CD89). Immunol. Lett. 92:23-31.
42. Pizza, M., et al. 2001. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19:2534-2541. (Pubitemid 32234269)
43. Randolph, G. J., S. Beaulieu, S. Lebecque, R. M. Steinman, and W. A. Muller. 1998. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282:480-483.
44. Randolph, G. J., K. Inaba, D. F. Robbiani, R. M. Steinman, and W. A. Muller. 1999. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753-761.
45. Randolph, G. J., J. Ochando, and S. Partida-Sanchez. 2008. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 26:293-316.
46. Rescigno, M. 2009. Before they were gut dendritic cells. Immunity 31:454-456.
47. - dendritic cells correlates with disease progression in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 46:519-528.
48. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
49. Sanarico, N., et al. 2006. Human monocyte-derived dendritic cells differentiated in the presence of IL-2 produce proinflammatory cytokines and prime Th1 immune response. J. Leukoc. Biol. 80:555-562.
50. Santini, S. M., et al. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191:1777-1788.
51. Schnitzler, A. C., J. M. Burke, and L. M. Wetzler. 2007. Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells. Infect. Immun. 75:3150-3159.
52. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7:19-30.
53. Shreedhar, V. K., B. L. Kelsall, and M. R. Neutra. 2003. Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T-and B-cell areas of Peyer's patches. Infect. Immun. 71:504-509.
54. Simmons, C. P., et al. 2001. Immunomodulation using bacterial enterotoxins. Scand. J. Immunol. 53:218-226.
55. Spangler, B. D. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622-647.
56. Steinman, R. M. 2000. DC-SIGN: a guide to some mysteries of dendritic cells. Cell 100:491-494.
57. Varol, C., et al. 2007. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204:171-180.
58. Varol, C., et al. 2009. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31:502-512.
59. Vendetti, S., M. Patrizio, A. Riccomi, and M. T. De Magistris. 2006. Human CD4+ T lymphocytes with increased intracellular cAMP levels exert regulatory functions by releasing extracellular cAMP. J. Leukoc. Biol. 80:880-888.
60. Willart, M. A., et al. 2009. The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen. J. Exp. Med. 206: 2823-2835.
61. Wilson, A. D., A. Robinson, L. Irons, and C. R. Stokes. 1993. Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen. Vaccine 11:113-118.